GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Shanghai Rongtai Health Technology Corp Ltd (SHSE:603579) » Definitions » Capex-to-Operating-Cash-Flow

Shanghai Rongtai Health Technology (SHSE:603579) Capex-to-Operating-Cash-Flow : 0.00 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Shanghai Rongtai Health Technology Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Shanghai Rongtai Health Technology's Capital Expenditure for the three months ended in Mar. 2025 was ¥-41.62 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2025 was ¥-34.48 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Shanghai Rongtai Health Technology Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Shanghai Rongtai Health Technology's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Rongtai Health Technology Capex-to-Operating-Cash-Flow Chart

Shanghai Rongtai Health Technology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.42 0.43 0.26 0.90

Shanghai Rongtai Health Technology Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.38 1.78 0.27 -

Competitive Comparison of Shanghai Rongtai Health Technology's Capex-to-Operating-Cash-Flow

For the Leisure subindustry, Shanghai Rongtai Health Technology's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Rongtai Health Technology's Capex-to-Operating-Cash-Flow Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Shanghai Rongtai Health Technology's Capex-to-Operating-Cash-Flow falls into.


;
;

Shanghai Rongtai Health Technology Capex-to-Operating-Cash-Flow Calculation

Shanghai Rongtai Health Technology's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-151.082) / 168.142
=0.90

Shanghai Rongtai Health Technology's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-41.618) / -34.477
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Rongtai Health Technology  (SHSE:603579) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Shanghai Rongtai Health Technology Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Shanghai Rongtai Health Technology's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Rongtai Health Technology Business Description

Traded in Other Exchanges
N/A
Address
No. 1226 ZhuFeng Road, Qingpu District, Shanghai, CHN, 201702
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
Executives
Cao Tao Supervisors
Ying Jian Sen Director
Lin Guang Sheng Director
Lin Qi Director

Shanghai Rongtai Health Technology Headlines

No Headlines